Trial intelligence / Profile preview

Melatonin for Chemotherapy Toxicity in Advanced Cancer

NCT01706627Phase 3Completed

Sponsor
Khon Kaen University
Start
Aug 2007
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in non-small cell lung cancer (NSCLC), breast cancer, head and neck cancer (HNC), sarcoma, sponsored by Khon Kaen University. Started Aug 2007; status: completed.

02

Drugs

melatonin
03

Conditions

non-small cell lung cancer (NSCLC)breast cancerhead and neck cancer (HNC)sarcoma

Beyond the preview

Go deeper on NCT01706627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01706627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call